Company intelligence / Profile preview

Hospira, Inc.

Lake Forest, Illinois, USApfizerhospitalus.com ↗

Ownership: Private
Employees: ~14000
Development stage: Commercial

Overview

Hospira was the world leader in generic injectable pharmaceuticals and infusion technologies with a growing biosimilars business. It had a broad commercial portfolio serving hospitals globally. The company expanded rapidly through acquisitions such as Mayne Pharma and Orchid’s injectable business. In September 2015, it was acquired by Pfizer for $17 billion to strengthen Pfizer's global established pharmaceutical business with leading positions in sterile injectables and biosimilars.

Therapeutic areas: OtherOncologyNeurologyInfectious Diseases
Modalities: Small molecules (generic injectables)BiosimilarsIV solutions/nutritionalsInfusion/medication management systems
Industry: Biotech

Drug pipeline

1 asset

TPN Electrolytes (Hospira, Inc.)

Approved

Partnerships

Strategic partnerships with Orchid Chemicals & Pharmaceuticals Ltd.various contract manufacturing relationships with major pharma companies pre-acquisition

Beyond the preview

Go deeper on Hospira, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hospira, Inc..

Explore the full profile